So much for stability at the U.S. FDA. Three weeks after accepting the position as director of the FDA’s CDER, Richard Pazdur has informed the agency of his intention to retire at the end of the year.
The Well News on MSN
FDA Draft Guidance Places New Limits on Toxicity Tests Involving Primates
WASHINGTON - The Food and Drug Administration released a draft guidance on Tuesday significantly reducing the range of ...
A longtime FDA official who took over last month as the agency’s top drug regulator intends to retire.The departure of ...
By Christy Santhosh Dec 2 (Reuters) - The U.S. Food and Drug Administration's drug evaluation chief, Richard Pazdur, is set ...
Background: Lakanwal is accused of shooting two West Virginia National Guard members who were deployed to D.C. to assist in ...
Weeks after Dr. Rick Pazdur accepted the position as the U.S. Food and Drug Administration's top drug regulator, he announced his resignation.
Top drug regulator Richard Pazdur filed papers to retire from the Food and Drug Administration at the end of this month, but ...
Weeks after being named head of CDER, Pazdur has submitted paperwork to step down at the end of the month, exacerbating what’s already been a turbulent year at the FDA.
Longtime FDA oncology leader and newly appointed Center for Drug Evaluation and Research director Richard Pazdur has filed ...
The US Food and Drug Administration’s longtime oncology chief has filed to retire from the agency just weeks after he was ...
Several news outlets, including Politico, CNN and the Washington Post, reported on December 2 that Food and Drug ...
Food and Drug Administration's newly appointed head of the drug evaluation department, Richard Pazdur, is set to retire ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback